Recombinant Anti-GBA (mutated E326K) antibody [EPR24900-273] (ab302607)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR24900-273] to GBA (mutated E326K)
- Suitable for: Flow Cyt (Intra), IHC-P, WB, Dot blot, IP, ICC/IF
- Reacts with: Human
Overview
-
Product name
Anti-GBA (mutated E326K) antibody [EPR24900-273]
See all GBA primary antibodies -
Description
Rabbit monoclonal [EPR24900-273] to GBA (mutated E326K) -
Host species
Rabbit -
Tested applications
Suitable for: Flow Cyt (Intra), IHC-P, WB, Dot blot, IP, ICC/IFmore details -
Species reactivity
Reacts with: Human -
Immunogen
Synthetic peptide. This information is proprietary to Abcam and/or its suppliers.
-
Positive control
- WB: HEK-293T transfected human GBA (E326K mutant) and WT GBA expression vector whole cell lysates, human spleen, fetal brain, and adrenal gland tissue lysates. DB: Human GBA peptide (E326K mutation + WT GBA) IHC-P:HEK-293T transfected human GBA (E326K mutation) and WT GBA expression vector whole cell pellets. ICC/IF: HEK-293T cell. Flow Cyt (Intra): HEK-293T cells transfected with a human GBA (E326K mutation) and WT GBA. IP: HEK-293T transfected with a human GBA (E326K mutation) whole cell lysate
-
General notes
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com.
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
Storage buffer
pH: 7.20
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA -
Concentration information loading...
-
Purity
Protein A purified -
Clonality
Monoclonal -
Clone number
EPR24900-273 -
Isotype
IgG -
Research areas
Associated products
-
Alternative Versions
-
Compatible Secondaries
-
Isotype control
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab302607 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
Flow Cyt (Intra) |
1/500.
|
|
IHC-P |
1/5000. Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
|
|
WB |
1/1000. Detects a band of approximately 60 kDa (predicted molecular weight: 60 kDa).
|
|
Dot blot |
1/1000.
|
|
IP |
1/30.
|
|
ICC/IF |
1/1000.
|
Notes |
---|
Flow Cyt (Intra)
1/500. |
IHC-P
1/5000. Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. |
WB
1/1000. Detects a band of approximately 60 kDa (predicted molecular weight: 60 kDa). |
Dot blot
1/1000. |
IP
1/30. |
ICC/IF
1/1000. |
Target
-
Involvement in disease
Defects in GBA are the cause of Gaucher disease (GD) [MIM:230800]; also known as glucocerebrosidase deficiency. GD is the most prevalent lysosomal storage disease, characterized by accumulation of glucosylceramide in the reticulo-endothelial system. Different clinical forms are recognized depending on the presence (neuronopathic forms) or absence of central nervous system involvement, severity and age of onset.
Defects in GBA are the cause of Gaucher disease type 1 (GD1) [MIM:230800]; also known as adult non-neuronopathic Gaucher disease. GD1 is characterized by hepatosplenomegaly with consequent anemia and thrombopenia, and bone involvement. The central nervous system is not involved.
Defects in GBA are the cause of Gaucher disease type 2 (GD2) [MIM:230900]; also known as acute neuronopathic Gaucher disease. GD2 is the most severe form and is universally progressive and fatal. It manifests soon after birth, with death generally occurring before patients reach two years of age.
Defects in GBA are the cause of Gaucher disease type 3 (GD3) [MIM:231000]; also known as subacute neuronopathic Gaucher disease. GD3 has central nervous manifestations.
Defects in GBA are the cause of Gaucher disease type 3C (GD3C) [MIM:231005]; also known as pseudo-Gaucher disease or Gaucher-like disease.
Defects in GBA are the cause of Gaucher disease perinatal lethal (GDPL) [MIM:608013]. It is a distinct form of Gaucher disease type 2, characterized by fetal onset. Hydrops fetalis, in utero fetal death and neonatal distress are prominent features. When hydrops is absent, neurologic involvement begins in the first week and leads to death within 3 months. Hepatosplenomegaly is a major sign, and is associated with ichthyosis, arthrogryposis, and facial dysmorphism.
Note=Perinatal lethal Gaucher disease is associated with non-immune hydrops fetalis, a generalized edema of the fetus with fluid accumulation in the body cavities due to non-immune causes. Non-immune hydrops fetalis is not a diagnosis in itself but a symptom, a feature of many genetic disorders, and the end-stage of a wide variety of disorders.
Defects in GBA contribute to susceptibility to Parkinson disease (PARK) [MIM:168600]. A complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability. Additional features are characteristic postural abnormalities, dysautonomia, dystonic cramps, and dementia. The pathology of Parkinson disease involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. The disease is progressive and usually manifests after the age of 50 years, although early-onset cases (before 50 years) are known. The majority of the cases are sporadic suggesting a multifactorial etiology based on environmental and genetic factors. However, some patients present with a positive family history for the disease. Familial forms of the disease usually begin at earlier ages and are associated with atypical clinical features. -
Sequence similarities
Belongs to the glycosyl hydrolase 30 family. -
Cellular localization
Lysosome membrane. Interaction with saposin-C promotes membrane association. - Information by UniProt
-
Database links
- Entrez Gene: 2629 Human
- Omim: 606463 Human
- SwissProt: P04062 Human
- Unigene: 282997 Human
- Unigene: 719930 Human
-
Alternative names
- Acid beta glucosidase antibody
- Acid beta-glucosidase antibody
- Alglucerase antibody
see all
Images
-
All lanes : Anti-GBA (mutated E326K) antibody [EPR24900-273] (ab302607) at 1/1000 dilution
Lane 1 : HEK-293T transfected with a human GBA (E326K mutation) expression vector containing a His-tag, whole cell lysate
Lane 2 : HEK-293T transfected with a human GBA (WT) expression vector containing a His-tag, whole cell lysate
Lane 3 : Human spleen tissue lysate
Lane 4 : Human fetal brain tissue lysate
Lane 5 : Human adrenal gland tissue lysate
Lysates/proteins at 20 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution
Predicted band size: 60 kDa
Observed band size: 60 kDa
Exposure time: 3 minutesBlocking / Diluting buffer and concentration: 5% NFDM/TBST
Negative in GBA (WT) transfected cells and GBA (WT)-expressing tissues.
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GBA (mutated E326K) antibody [EPR24900-273] (AB302607)
Immunohistochemical analysis of paraffin-embedded HEK-293T cells transfected with a human GBA E365K expression vector containing a myc-His tag (Cell Pellet) (A) labeling GBA (mutated E326K) with ab302607 at 1/5000 dilution (0.094 µg/mL), and HEK-293T cells transfected with a human GBA expression vector containing a myc-His tag (Cell Pellet) (B), and HEK-293T transfected with an empty vector (Cell Pellet) (C) followed by a ready to use Leica DS9800 (Bond™ Polymer Refine Detection kit). Cytoplasmic staining on HEK-293T cells observed (Image A). No staining on HEK-293T cells transfected with a human WT GBA expression vector containing a myc-His tag cell pallet (image B) and 293T transfected with an empty vector cell pallet (image C). The section was incubated with ab302607 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control: Primary diluent was used instead of primary antibody, followed by a ready to use secondary antibody Leica DS9800 (Bond™ Polymer Refine Detection kit).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GBA (mutated E326K) antibody [EPR24900-273] (AB302607)
Immunohistochemical analysis of paraffin-embedded human breast cancer tissue for labeling GBA (mutated E326K) with ab302607 at 1/5000 dilution (0.094 µg/mL) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection kit). Negative control: No staining on human breast. The section was incubated with ab302607 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.
-
Immunocytochemistry/ Immunofluorescence - Anti-GBA (mutated E326K) antibody [EPR24900-273] (AB302607)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HEK-293 (Human epithelial cells from embryonic kidney) cells transfected with a human GBA E365K expression vector containing a Myc tag and HEK-293T cells transfected with a human GBA expression vector. Confocal image showing cytoplasmic staining in HEK-293T cells transfected with a human GBA E365K expression vector and no staining in HEK-293T cells transfected with only a human GBA expression vector. ab302607 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed (ab150081) secondary antibody at 1/1000 dilution (green). The nuclear counter stain is DAPI (blue).
Counterstain antibody was a anti-Myc-Tag Mouse mAb (Alexa Fluor® 647) (Red).
Secondary antibody only control: primary diluent was used instead of primary antibody followed by preadsorbed ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) at 1/1000 dilution.
-
Flow cytometric scatter graph showing 4% paraformaldehyde fixed and 90% methanol permeabilized HEK-293T (human embryonic kidney) cells transfected with a human GBA (WT) expression vector containing a myc-his tag (Left) and HEK-293T transfected with a human GBA (mutated E326K) expression vector containing a myc-his tag labeling GBA (mutated E326K) (Right). ab302607 at 1/500 dilution (0.1μl). Secondary antibody was Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) used at 1/2000 dilution.
-
GBA (mutated E326K) was immunoprecipitated from 10μg of HEK-293T transfected with a human GBA (E326K mutation) expression vector containing a His-tag whole cell lysate, with ab302607 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab302607 at 1/1000 dilution. VeriBlot for IP secondary antibody (HRP) (ab131366) was used as secondary antibody at 1/5000 dilution.
Lane 1: HEK-293T transfected with a human GBA (E326K mutation) expression vector containing a His-tag, whole cell lysate (Input).
Lane 2: ab302607 IP in HEK-293T transfected with a human GBA (E326K mutation) expression vector containing a His-tag, whole cell lysate.
Lane 3: Rabbit monoclonal IgG (ab172730) instead of ab302607 in HEK-293T transfected with a human GBA (E326K mutation) expression vector containing a His-tag, whole cell lysate.
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
Exposure time: 49 seconds.
Observed MW(KDa): 60
-
Dot blot analysis of GBA (mutated E326K) with ab302607 at a dilution of 1/1000 (0.472 μg/ml). ab97051 (Peroxidase conjugated goat anti-rabbit IgG (H+L)) was used as the secondary antibody at a dilution of 1/100000.
Lane 1: Human GBA peptide a containing E326K mutation
Lane 2: Lane 2: Human GBA peptide b containing E326K mutation
Lane 3: Lane 3: Human WT GBA peptide corresponding to the E326K-mutated peptide
Blocking and dilution buffer: 5% NFDM/TBST.
Exposure time: 3 minutes.
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
Certificate of Compliance
References (0)
ab302607 has not yet been referenced specifically in any publications.